Sarepta Therapeutics (SRPT) Sees Wild Late-Day Action
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Join SI Premium – FREE
After trading up most of the session, shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) are seeing whipsaw trading into the close. The action appears related to a presentation at a CSH Lab meeting.
While nothing new was reported on eteplirsen, according to a tweet from theStreet.com's biotech writer Adam Feuerstein @adamfeuerstein, who is at the event - "Scientist from PTC Therapeutic throwing skeptical questions at $SRPT presenter. Questioning the "realness" of placebo pat decline in 6MWT."
While nothing new was reported on eteplirsen, according to a tweet from theStreet.com's biotech writer Adam Feuerstein @adamfeuerstein, who is at the event - "Scientist from PTC Therapeutic throwing skeptical questions at $SRPT presenter. Questioning the "realness" of placebo pat decline in 6MWT."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic plans IPO potentially exceeding SpaceX's $86B record - Bloomberg
- Scorpion Capital says short Twist Biosciences
- Deere conference call: 2027 orders up mid-single digits from last year)
Create E-mail Alert Related Categories
Trader TalkRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
